Form D · Biotechnology
Mitogenetics, LLC
Sioux Falls, SD · CIK 0001511439
Offering snapshot reported May 2, 2016 · SEC filing
- Reported sold
- $2.48M Offering amount: $5M
- Investors reported
- 99 Form D · investor count
- Minimum accepted
- $11K Reported outside-investor minimum
- First sale
- Nov 13, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$275,000 → $2,481,000
- Reported investors11 → 99
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 2, 2016 | Amendment | $2,481,000 | $2,206,000vs Dec 9, 2014 | 99 | SEC filing |
| Dec 9, 2014 | Amendment | $275,000 | No comparison | 11 | SEC filing |
| Oct 23, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 3, 2014 | Amendment | $1,485,000 | $1,445,000vs Jul 5, 2013 | 47 | SEC filing |
| Jul 5, 2013 | Initial | $40,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-227058
Source: Form D, filed May 2, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Atwood | Director |
| Walt Bones | Director |
| E. Charles Brice | Director |
| Mark Graczynski | Director |
| Marcia Hendrickson | Director, Executive |
| Brian Minish | Executive |
| Brad Nelson | Director |
| Ivan Paulson | Director, Executive |
| Evan Rayl | Director, Executive |
| Max Rogers | Director |
| Brad Saeger | Director, Executive |
| Leon Schwartz | Director, Executive |
| Nick Sershen | Executive |
| Steve Sershen | Executive |
| George Stefano | Director, Executive |
| William Switzer | Director, Executive |
| Isaac Tessmer | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2329 N. Career Avenue, Suite 316
Sioux Falls, SD, 57107
Sioux Falls, SD, 57107